Background illustration for clinical trials search

Paid Clinical Trials Warwick

Discover 491 paid clinical trials in Warwick, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Feasibility and Acceptability of a Novel Digital Intervention to Prevent Paternal Postpartum Depression

for
Paternal Postpartum Depression, Postpartum Anxiety
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island

Sex: All

Age: 18+

Code: NCT07594743

Recruiting

Combined Oral Motor Stimulation and Language on Preterm Infant Feeding

for
Language Delay, Language Development,
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island

Sex: All

Age: 0

Code: NCT05861531

Recruiting

Early Diagnosis and Intervention for Fetal Malposition in Active Labor and Its Impact on Mode of Delivery

for
Cesarean Delivery Affecting Fetus, Labor Dystocia,
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island

Sex: Female

Age: 18+

Code: NCT05881629

Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

for
Endometrial Adenocarcinoma,
Location: Providence RI, Scarborough ME, Syracuse NY,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05112601

Phase 2, Recruiting

E-Mindfulness Approaches for Living After Breast Cancer

for
Breast Cancer, Depression
Location: Providence RI, Boston MA, Burlington MA, Stoneham MA,
Sponsor: NRG Oncology

Sex: All

Age: 18 - 50

Code: NCT06748222

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: Providence RI, Boston MA, New Haven CT, Mineola NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase 3, Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: Providence RI, Boston MA, Stoneham MA, Springfield MA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase 2, Recruiting

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

for
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary,
Location: Providence RI, New Haven CT, New York NY, Baltimore MD,
Sponsor: Volastra Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05902988

Phase 1, Phase 2, Recruiting

Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, Boston MA, New Haven CT,
Sponsor: Debiopharm International SA

Sex: All

Age: 12+

Code: NCT04855656

Phase 1, Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for
Ovarian Carcinoma
Location: Providence RI, Waterford CT, Boston MA, Hartford CT,
Sponsor: NRG Oncology

Sex: Female

Age: 35 - 50

Code: NCT04251052

Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

for
Endometrial Adenocarcinoma
Location: Providence RI, Boston MA, New York NY, Hackensack NJ,
Sponsor: Acrivon Therapeutics

Sex: Female

Age: 18+

Code: NCT05548296

Phase 2, Recruiting

Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy

for
Postoperative Bleeding, Gender Dysphoria, Hysterectomy
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island

Sex: Female

Age: 18+

Code: NCT06969326

Phase 3, Recruiting

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

for
Cervical Cancer
Location: Providence RI, Manchester CT, Hartford CT,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT04831580

Recruiting

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

for
Cervical Cancer
Location: Providence RI, Brooklyn NY, Voorhees Township NJ,
Sponsor: Pfizer

Sex: Female

Age: 18+

Code: NCT06952660

Phase 4, Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

for
Malignant Female Reproductive System Neoplasm,
Location: Providence RI, Scarborough ME, Jersey City NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06126276

Phase 2, Recruiting

Nebivolol Effects on Endothelial Function and Erectile Function

for
Erectile Dysfunction
Location: Providence RI
Sponsor: Martin M. Miner, MD

Sex: Male

Age: 25 - 65

Code: NCT01885988

Recruiting

Screening Emotions in Adolescents at the Hospital for mTBI

for
Brain Injury Traumatic Mild, Brain Injuries,
Location: Providence RI, Philadelphia PA, Milwaukee WI, Dallas TX,
Sponsor: University of California, Davis

Sex: All

Age: 11 - 17

Code: NCT06370520

Recruiting

Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study

for
Intubation Complication
Location: Providence RI, Charlottesville VA, Akron OH, Atlanta GA,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 19

Code: NCT06085326

Recruiting

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

for
Neuroblastoma, Ewing Sarcoma, Osteosarcoma, Rhabdomyosarcoma,
Location: Providence RI, Hartford CT, Hackensack NJ, Montreal,
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 0 - 30

Code: NCT06541262

Phase 1, Phase 2, Recruiting

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

for
Medulloblastoma
Location: Providence RI, Hartford CT, Hackensack NJ, Hershey PA,
Sponsor: Giselle Sholler

Sex: All

Age: 0 - 21

Code: NCT04696029

Phase 2, Recruiting